Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 792

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Radiotherapy for Glioblastoma in the Elderly

Keime-Guibert, Florence, Chinot, Olivier, Taillandier, Luc, Cartalat-Carel, Stéphanie, Frenay, Marc, Kantor, Guy, Guillamo, Jean-Sébastien, Jadaud, Eric, Colin, Philippe, Bondiau, Pierre-Yves, Meneï, Philippe, Loiseau, Hugues, Bernier, Valérie, Honnorat, Jérôme, Barrié, Maryline, Mokhtari, Karima, Mazeron, Jean-Jacques, Bissery, Anne, Delattre, Jean-Yves·2007·New England Journal of Medicine

Abstract

BACKGROUND: There is no community standard for the treatment of glioblastoma in patients 70 years of age or older. We conducted a randomized trial that compared radiotherapy and supportive care with supportive care alone in such patients. METHODS: Patients 70 years of age or older with a newly diagnosed anaplastic astrocytoma or glioblastoma and a Karnofsky performance score of 70 or higher were randomly assigned to receive supportive care only or supportive care plus radiotherapy (focal radiation in daily fractions of 1.8 Gy given 5 days per week, for a total dose of 50 Gy). The primary end point was overall survival; secondary end points were progression-free survival, tolerance of radiotherapy, health-related quality of life, and cognition. RESULTS: We randomly assigned 85 patients from 10 centers to receive either radiotherapy and supportive care or supportive care alone. The trial was discontinued at the first interim analysis, which showed that with a preset boundary of efficacy, radiotherapy and supportive care were superior to supportive care alone. A final analysis was carried out for the 81 patients with glioblastoma (median age, 73 years; range, 70 to 85). At a median follow-up of 21 weeks, the median survival for the 39 patients who received radiotherapy plus supportive care was 29.1 weeks, as compared with 16.9 weeks for the 42 patients who received supportive care alone. The hazard ratio for death in the radiotherapy group was 0.47 (95% confidence interval, 0.29 to 0.76; P=0.002). There were no severe adverse events related to radiotherapy. The results of quality-of-life and cognitive evaluations over time did not differ significantly between the treatment groups. CONCLUSIONS: Radiotherapy results in a modest improvement in survival, without reducing the quality of life or cognition, in elderly patients with glioblastoma. (ClinicalTrials.gov number, NCT00430911 [ClinicalTrials.gov].).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa065901

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 792

Metadata

Authors
Keime-Guibert, F., Chinot, O., Taillandier, L., Cartalat-Carel, S., Frenay, M., Kantor, G., Guillamo, J.-S., Jadaud, E., Colin, P., Bondiau, P.-Y., Meneï, P., Loiseau, H., Bernier, V., Honnorat, J., Barrié, M., Mokhtari, K., Mazeron, J.-J., Bissery, A., & Delattre, J.-Y.
Venue
New England Journal of Medicine
Published
2007-04-12
Volume
356
Issue
15
Pages
1527-1535
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2133611748
Cited by
792
References
2
FWCI
18.90
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Radiotherapy for Glioblastoma in the Elderly. https://app.cochat.ai/papers/10.1056/nejmoa065901
The paper
Keime-Guibert, F., Chinot, O., Taillandier, L., Cartalat-Carel, S., Frenay, M., Kantor, G., Guillamo, J.-S., Jadaud, E., Colin, P., Bondiau, P.-Y., Meneï, P., Loiseau, H., Bernier, V., Honnorat, J., Barrié, M., Mokhtari, K., Mazeron, J.-J., Bissery, A., & Delattre, J.-Y. (2007). Radiotherapy for Glioblastoma in the Elderly. New England Journal of Medicine. https://doi.org/10.1056/nejmoa065901

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.